Skip directly to content

FAQs

What is Pfizer looking for?
  • Clearly defined market need – for your defined market, you must be able to show the need for your solution.
  • Innovative solutions that support: Self-care, health awareness, monitoring and information, earlier detection and better diagnostics, treatment optimisation, pathway improvement, data-enabled decision-making, improved communication for care, social and psychological support
  • Patient impact: Pfizer’s purpose is to, “Innovate to bring therapies to patients that significantly improve their lives”, we work with entrepreneurs with the same vision. Even if the impact comes indirectly through improving NHS or providers’ workflow you need to be able to explain how your digital innovation could make a meaningful impact for users
  • Proven technology: The Hub supports entrepreneurs to scale up, an idea is not enough, this competitive grant process is for late stage digital health start-up companies. Some real world data from a pilot, a beta or evidence from early adoption of the innovation may be sufficient for most applicants. If your application is for a product classified as a medical device you will also need to provide evidence of CE marking.
  • Feasibility: Knowing your value and keeping your solution as simple as it needs to be, is critical. You need to understand some of the challenges across the UK health economy and how your innovation can succeed in this context. You will have identified what it is that you require in order to grow.
  • Scalability: Variations in care are a real challenge for patients and funders in the developed and developing economies. We are looking for companies with the potential to scale across boundaries in systems or geographies.
Who can apply to the CGP process?

Any legal entity in the UK who possesses the attributes we are looking for may apply. All applications are required to be submitted through this online portal only.

Will Pfizer take any equity or claim ownership of any intellectual rights to the technology?

Pfizer has no commercial interest in the applicants’ business and will not take any equity or make claims on the applicants’ intellectual property.

What happens after the submission?

The Pfizer Healthcare Hub: London team will review all the applications and contact you by 27th April 2018 if you are shortlisted for the pitch event.

Shortlisted companies will be asked to support any claims made such as evidence of the CE mark where relevant.

Up to 10 shortlisted companies will be invited to submit short elevator videos (<60 seconds) by 4th May 2018 for the Hub to share internally with UK Pfizer colleagues and the many more beyond to help you generate as much support for your application as possible from every corner of our business.

Shortlisted companies will be invited to attend a live pitch and assessment day on 17th May at Pfizer UK headquarters, Walton Oaks, Surrey. You can see the highlights here.

As a leading biopharmaceutical company we take our commitments to the public, patients and providers seriously and shortlisted companies may be asked to engage in appropriate due diligence tailored to their proposition.

From June 2018 up to three winners of the CGP process will join the Pfizer Healthcare Hub: London as collaborative partners.

Unsuccessful applicants could be contacted to inform them of any alternative opportunities that may meet their needs.  

What if I am involved in another accelerator programme?

You are free to be part of any other accelerator programme and talk to any other potential partners to pursue any exit options with other companies.

Will you provide finance for my business?

The competitive grant offers up to £50,000 to be shared between the selected winner(s). You can apply for funding for whatever you feel will have the greatest impact on achieving your goals. You may be eligible to access other Pfizer grants and competitions during the programme as a Hub collaborator.

When will the programme begin and what is the duration?

The programme will begin in June 2018 with a bespoke workshop to explore your ambitions as a winner and the duration will be up to twelve months following that. If your growth strategy is to expand to other markets this year you may choose a shorter collaboration period in the UK and use our support to help you engage with one of our other global Hubs or programmes.

Will the programme be extended beyond twelve months?

This decision would need to be agreed by both parties at the end of the programme.

What can we expect from the programme?

A personalised programme of mentoring, consulting and support for marketing and collaborating, as well as access to Pfizer’s know-how and support, to work with those beyond Pfizer who can help you have the biggest impact. The Hub is part of Pfizer UK’s Healthcare Operations team. A dedicated Hub team, including the Hub manger and a network of navigators, are supported by Pfizer’s global Director of Worldwide Innovation, UK and European colleagues to provide connections across the business and allow you to get the most from the scheme.

What happens after the programme ends?

This will depend on the individual businesses, but may include extended partnership and invitation for further collaboration opportunities.

Who will this programme benefit?

Applicants with a digital innovation that can show how they could improve the lives of patients, directly or indirectly, by addressing the needs of the NHS or healthcare providers.

The Healthcare Hub is designed to support those companies who are ready to scale, to reach more patients or providers. If you are struggling to find the agents of change in your local healthcare network, if you are looking for support to understand your local market or new markets, advice on growing your team, support developing plans for investors or reaching patient groups then working with the Hub could help.

I’m still not sure if I qualify?

Have a look at our Legal section for more details, after that, feel free to apply anyway. We can clarify if you meet the eligibility criteria to enter but will not provide specific feedback on your application beyond that until after the competition closes.